BRAF inhibitor treatment in classic hairy cell leukemia: a long-term follow-up study of patients treated outside clinical trials

Leukemia. 2020 May;34(5):1454-1457. doi: 10.1038/s41375-019-0646-y. Epub 2019 Nov 18.

Nora Liebers^{1

2}, Tobias Roider^{1

3}, Jan-Paul Bohn⁴, Isabella Haberbosch¹, Andreas Pircher⁴, Barbara Ferstl⁵, Monika Ebnöther⁶, Clemens-Martin Wendtner⁷, Claire Dearden⁸, George A Follows⁹, Anthony D Ho¹, Carsten Müller-Tidow^{1

2}, Peter Dreger¹, Xavier Troussard¹⁰, Thorsten Zenz¹¹, Sascha Dietrich^{12

13

14}

¹ Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
² National Center for Tumor Diseases and German Cancer Research Center, Heidelberg, Germany.
³ European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.
⁴ Department of Internal Medicine V, Division of Hematology & Oncology, Medical University of Innsbruck, Innsbruck, Austria.
⁵ Department of Medicine 5, Universitätsklinikum Erlangen, Erlangen, Germany.
⁶ Department of Hematology and Oncology, St. Claraspital, Basel, Switzerland.
⁷ Department of Hematology, Oncology, Immunology, Palliative Care, Infectious Diseases and Tropical Medicine, Hospital Munich-Schwabing, Munich, Germany.
⁸ The Royal Marsden Hospital, London, UK.
⁹ Department of Hematology, Addenbrookes Hospital, Cambridge, UK.
¹⁰ CHU de Caen, laboratoire d'hématologie, Caen, France.
¹¹ Division of Medical Oncology and Hematology, Universitätsspital Zürich, Zürich, Switzerland.
¹² Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany. [email protected].
¹³ National Center for Tumor Diseases and German Cancer Research Center, Heidelberg, Germany. [email protected].
¹⁴ European Molecular Biology Laboratory (EMBL), Heidelberg, Germany. [email protected].

No abstract available

Publication types